(This story has been corrected to fix the spelling of the company name in the headline, and to add a dropped word ‘to,’ in paragraph 3) MADRID (Reuters) -Grifols’s net profit almost tripled from a year earlier, which the Spanish drugmaker said reinforced its confidence in meeting its full-year guidance. Reported group profit grew by […]
Health
Grifols says on course to meet 2025 outlook as net profit triples
Audio By Carbonatix
(This story has been corrected to fix the spelling of the company name in the headline, and to add a dropped word ‘to,’ in paragraph 3)
MADRID (Reuters) -Grifols’s net profit almost tripled from a year earlier, which the Spanish drugmaker said reinforced its confidence in meeting its full-year guidance.
Reported group profit grew by 179% in the first three months of the year to 60 million euros ($66.41 million) while adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) grew 14.2% to 400 million euros, Grifols said in a statement on Monday.
Net revenue rose 7.4% to 1.79 billion euros in the first quarter thanks to a strong performance from its plasma-derived medicine business.
($1 = 0.9035 euros)
(Reporting by Charlie Devereux; editing by Inti Landauro)